BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
| 1.5 | |
| 1.8 | |
| - | |
| 1.6 | |
| 1.82 | |
| 1.415-4.61 | |
| 32 334 K | |
| 21 848 K | |
| 56 262 K | |
| 1.279 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
BRAIN Biotech (ETR:BNN) First Quarter 2023 Results Key Financial Results Revenue: €14.1m (up 36% from 1Q 2022). Net loss: €2.53m (loss widened by 7.3% from 1Q 2022). €0.12 loss per share (furt...
B.R.A.I.N. Biotechnology Research and Information Network AG (ETR:BNN) shareholders will doubtless be very grateful to see the share price up 54% in the last month. But that doesn't help the fact that...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
